Comparison of twice-daily stavudine plus once- or twice-daily didanosine and nevirapine in early stages of HIV infection: the Scan Study-Reference-Cited by-同舟云学术

Comparison of twice-daily stavudine plus once- or twice-daily didanosine and nevirapine in early stages of HIV infection: the Scan Study

Published:2000-11 Issue:16 Volume:14 Page:2485-2494
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:AIDS

Author:

García Felipe,Knobel Hernando,Sambeat Maria Antonia,Arrizabalaga Julio,Aranda Miquel,Romeu Joan,Dalmau David,Segura Ferran,Gomez-Sirvent Juan Luis,Ferrer Elena,Cruceta Anna,Gallart Teresa,Pumarola Tomas,Miró Jose M,Gatell Jose M

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference34 articles.

1. Antiretroviral Therapy in Adults

2. A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less

3. Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in Adults

4. Adherence and Effectiveness of Highly Active Antiretroviral Therapy

5. A Randomized, Double-blind Trial Comparing Combinations of Nevirapine, Didanosine, and Zidovudine for HIV-Infected Patients

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Nevirapine Plasma Concentrations between Lead-In and Steady-State Periods in Chinese HIV-Infected Patients;PLoS ONE;2013-01-24

2. Nevirapine extended-release for the treatment of HIV-1 infection;Expert Review of Anti-infective Therapy;2012-01

3. Twenty Years of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: Time to Reevaluate their Toxicity;Current Medicinal Chemistry;2011-05-01

4. Once-a-Day (QD) vs Twice-Daily (BID) Nevirapine as Simplification in PITreated Patients After 2 mos. of BID Induction;Current HIV Research;2011-04-01

5. Phenotypic and functional characteristics of HIV-specific CD8 T cells and gag sequence variability after autologous dendritic cells based therapeutic vaccine;Vaccine;2009-10